Novel mechanism of transcriptional activation of hepatic LDL receptor by oncostatin M

Journal of Lipid Research

Volumn 38, Issue 10, 1997, Pages 2035-2048

  Liu, Jingwen ^a,d   Streiff, Raphael ^a   Zhang, Y Lynda ^a   Vestal, Robert E ^a,b   Spence, Michael J ^a   Briggs, Michael R ^c  

^a St Luke's Mountain States Tumor Institute   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c LIGAND PHARMACEUTICALS INC   (United States)

^d Endocrinology Division   (United States)

Author keywords

Cholesterol suppression; Cytokines; Gene transcription; Transcriptional activation

Indexed keywords

LOW DENSITY LIPOPROTEIN RECEPTOR; LUCIFERASE; ONCOSTATIN M; TRANSCRIPTION FACTOR SP1;

ARTICLE; CELL STRAIN HEPG2; GENE MUTATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; TRANSACTIVATION;

BLOTTING, NORTHERN; CARCINOMA, HEPATOCELLULAR; CHOLESTEROL; CLONING, MOLECULAR; CYTOKINES; DNA PROBES; GENES, REPORTER; HUMANS; LIVER; MUTAGENESIS, SITE-DIRECTED; ONCOSTATIN M; PEPTIDES; PROMOTER REGIONS (GENETICS); RECEPTORS, LDL; REPETITIVE SEQUENCES, NUCLEIC ACID; RNA, MESSENGER; SP1 TRANSCRIPTION FACTOR; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0030700025     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Brown, M. S., and J. L. Goldstein. 1986. A receptor-mediated pathway for cholesterol homeostasis. Science. 232: 34-47.
2. Reed, D. M., J. P. Strong, J. Resell, and T. Hayashi. 1989. Serum lipids and lipoproteins as predictors of atherosclerosis: an autopsy study. Arteriosclerosis. 9: 560-564.
3. Goldstein, J. L., and M. S. Brown. 1990. Regulation of the mevalonate pathway. Nature. 343: 425-430.
4. Sudhof, T. C., D. R. Van der Westhuyzen, J. L. Goldstein, M. S. Brown, and D. W. Russell. 1987. Three direct repeats and a TATA-like sequence are required for regulated expression of the human low density lipoprotein receptor gene. J. Biol. Chem. 262: 10773-10779.
5. Dawson, P. A., S. L. Hofmann, D. R. Van der Westhuyzen, T. C. Sudhof, M. S. Brown, and J. L. Goldstein. 1988. Sterol-dependent repression of low-density lipoprotein receptor promoter mediated by 16-base pair sequence adjacent to binding site for transcription factor Sp1. J. Biol. Chem. 263: 3372-3379.
6. Sudhof, T. C., D. W. Russell, M. S. Brown, and J. L. Goldstein. 1987. 42 bp element from LDL receptor gene confers end-product repression by sterols when inserted into viral TK promoter. Cell. 48: 1061-1069.
7. Smith, J. R., T. F. Osborne, J. L. Goldstein, and M. S. Brown. 1990. Identification of nucleotides responsible for enhancer activity of sterol regulatory element in low density lipoprotein receptor gene. J. Biol. Chem. 265: 2306-2310.
8. Briggs, M. R., C. Yokoyama, X. Wang, M. S. Brown, and J. L. Goldstein. 1993. Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promoter. J. Biol. Chem. 268: 14490-14496.
9. Wang, X., M. R. Briggs, X. Hua, C. Yokoyama, J. L. Goldstein, and M. S. Brown. 1993. Nuclear protein that binds sterol regulatory element of low density lipoprotein receptor promoter II. Purification and characterization. J. Biol. Chem. 268: 14497-14504.
10. Yokoyama, C., X. Wang, M. R. Briggs, A. Admon, J. Wu, X. Hua, J. L. Goldstein, and M. S. Brown. 1993. SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene. Cell. 75: 187-197.
11. Hua, X., C. Yokoyama, J. Wu, M. R. Briggs, M. S. Brown, J. L. Goldstein, and X. Wang. 1993. SREBP-2, a second basic-helix-loop-helix-leucine zipper protein that stimulates transcription by binding to a sterol regulatory element. Proc. Natl. Acad. Sci. USA. 90: 11603-11607.
12. Wang, X., R. Sato, M. S. Brown, X. Hua, and J. L. Goldstein. 1994. SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis. Cell. 77: 53-62.
13. Sanchez, H. B., L. Yieh, and T. F. Osborne. 1995. Cooperation by sterol regulatory element-binding protein and Sp1 in sterol regulation of low density lipoprotcin receptor gene. J. Biol. Chem. 270: 1161-1169.
14. Pak, Y. K., M. P. Kanuck, D. Berrios, M. R. Briggs, A. D. Cooper, and J. L. Ellsworth. 1996. Activation of LDL receptor gene expression in HepG2 cells by hepatocyte growth factor. J. Lipid Res. 37: 985-998.
15. Evans, R. D., J. M. Argiles, and D. H. Williamson. 1989. Metabolic effects of tumor necrosis factor-alpha (cachectin) and interleukin-1. Clin. Sci. 77: 357-364.
16. Foa, R., A. Guarini, Di. C. P. Francia, L. Trentin, T. A. Gillio, G. Bellone, A. Carbone, C. Attiaano, M. Massaia, D. Respadori, G. Pizzolo, T. Chiseal, F. Lauria, and G. Semenzato. 1992. Constitutive production of tumor necrosis factor-alpha in hairy cell leukemia: possible role in the pathogenesis of the cytopenia (s) and effect of treatment with interferon-alpha. J. Clin. Oncol. 10: 954-959.
17. Grunfeld, C., and K. Feingold. 1992. Metabolic disturbance and wasting in the acquired immunodeficiency syndrome. N. Engl. J. Med. 327: 329-337.
18. Grunfeld, C., D. P. Kotler, J. K. Shigenaga, W. Doerrler, A. Tierney, J. Wang, R. N. Pierson, Jr., and K. R. Feingold. 1991. Cumulating interferon-alpha levels and hypertriglyceridemia in the acquired immunodeficiency syndrome. Am. J. Med. 90: 154-162.
19. Sammalkorpi, K., V. Valtonen, Y. Kertulla, E. Nikkila, and M. Taskinen. 1988. Changes in serum lipoprotein pattern induced by acute infection. Metabolism. 37: 859-965.
20. Riikonen, P., U. M. Saarinen, A. M. Teppo, K. Metaarinne, F. Fyhrqnist, and H. Jalanko. 1992. Cytokine and acute-phase reactant levels in serum of children with cancer admitted for fever and neutropenia. J. Inject. Dis. 166: 432-436.
21. Stopeck, A. T., A. C. Nicholson, F. P. Mancini, and D. P. Haijar. 1993. Cytokine regulation of low density lipoprotein receptor gene transcription in HepG2 cells. J. Biol. Chem. 268: 17489-17494.
22. Grove, R. I., C. E. Mazzucco, S. F. Radka, and M. Shoyab. 1991. Oncostatin M upregulates LDL receptor in HepG2 cells by a novel mechanism. J. Biol. Chem. 266: 18194-18199.
23. Litt, J., R. I. Grove, and R. E. Vestal. 1994. Oncostatin M activates the LDL receptor gene transcription in sterol-repressed liver cells. Cell Growth. & Differ. 5: 1333-1338.
24. Malik, N., D. Graves, M. Shoyab, and A. F. Purchio. 1992. Amplification and expression of heterologous oncostatin M in Chinese hamster ovary cells. DNA Cell. Biol. 11: 453-459.
25. Goldstein, J. L., S. K. Basu, and M. S. Brown. 1983. Receptor-mediated endocytosis of low-density lipoprotein in cultured cells. Methods Enzymol. 98: 241-200.
26. Salvatori, R., R. S. Bockman, and P. T. Guidon, Jr. 1992. A simple modification of the Peppel/Baglioni method for RNA isolation from cell culture. BioTecniques. 13: 510-512.
27. Greenberg, M. E., and T. P. Bender. 1995. Identification of newly transcribed RNA. In Current Protocols in Molecular Biology. Unit 4.10. F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl, editors. John Wiley & Sons, New York.
28. Dignam, J. D., R. M. Lebovitz, and R. C. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11: 1475-1489.
29. Bennett, M. K., J. M. Lopez, H. B. Sanchez, and T. F. Osborne. 1995. Sterol regulation of fatty acid synthase promoter, coordinate feedback regulation of two major lipid pathways. J. Biol. Chem. 270: 25578-25583.
30. Liu, J., B. Modrell, A. Aruffo, J. S. Marken, T. Taga, M. Murakami, K. Yasukawa, T. Kishimoto, and M. Shoyab. 1992. Interleukin-6 signal transducer gp130 mediates oncostatin M signaling. J. Biol. Chem. 267: 16763-16766.
31. Liu, J., B. Modrell, A. Aroffo, S. Scharnowske, and M. Shoyab. 1994. Interactions between oncostatin M and the IL-6 signal transducer, gp130. Cytokine. 6: 272-278.
32. Bugno, M., L. Graeve, P. Gatsios, A. Koj, P. C. Heinrich, J. Travis, and T. Kordula. 1995. Identification of the interleukin-6/oncostatin M response element in the rat tissue inhibitor of metalloproteinases-1 (TIMP-1) promoter. Nucleic Acids Res. 23: 5041-5047.
33. Wade, D. P., B. L. Knight, and A. K. Soutar. 1989. Regulation of low density lipoprotein receptor mRNA by insulin in human hepatoma HepG2 cells. Eur. J. Biochem. 181: 727-731.
34. Liao, W., and C. H. Floren. 1993. Tumor necrosis factor up-regulates expression of low density lipoprotein receptors on HepG2 cells. Hepatology. 17: 898-907.
35. Moorby, C. D., E. Gherardi, L. Dovey, C. Godliman, and D. E. Bowyer. 1992. Transforming growth factor-β1 and interleukin-1β stimulate LDL receptor activity in HepG2 cells. Atherosclerosis. 97: 21-28.
36. Ellsworth, J. L., C. Chandrasekaran, and A. D. Cooper. 1991. Evidence of sterol-independent regulation of LDL receptors by a serum factor in HepG2 cells. Biochem. J. 279: 175-187.
37. Pak, Y. M. 1996. Serum response element-like sequences of the human low density lipoprotein receptor promoter: possible regulation sites for sterol-independent transcriptional activation. Biochem. Mol. Biol. Int. 38: 31-36.
38. Hagen, G., S. Muller, M. Beato, and G. Suske. 1994. Sp1-mediated transcriptional activation is repressed by Sp3. EMBO J. 13: 3843-3851.
39. Sjottem, E., S. Anderssen, and T. Johansen. 1996. The promoter activity of long terminal repeats of the HERV-H family of human retrovirus-like elements is critically dependent on Sp1 family proteins interacting with a GC/GT box located immediately 3′ to the TATA box. J. Virol. 70: 188-198.